Published Research

Our experience

We have considerable experience in conducting market research for publications in peer-reviewed medical journals and for presentation at medical conferences.

• M.B.Y.Tang, M.Fatani, S.Wiggins, J.Maspero, Physician Perception of Disease Severity and Treatment Outcomes for Children and Adolescents with Atopic Dermatitis in Emerging Economies (2022)
• R. Howard, R.N.Barrantes, A.Simms, The challenges of generating patient-relevant outcomes and other evidence sufficient to satisfy European HTA bodies in acute conditions managed in the ICU. ISPOR 2022
• F.R.Santiago, J.Ulloa, C.Regnier, T.Peudon, E.Braund, C.Fradet-Aubignat, S Gianesini The impact of lower limb chronic venous disease on quality of life: patient and physician perspectives (2022)
• Janssen ‘The burden of a multiple myeloma diagnosis on patients and carers in the first year: Western European findings’. EHA (2021) Jenny Redfearn and Victoria Spain
• Ease of use and functionality of the newly developed AllStar®PRO versus the ClikSTAR®insulin pen: experience of people with diabetes and diabetes nurse educators (2018) Thomas Haak, Richard Head, Houda Mihad and Frank Flacke
• Mundipharma (2018) Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion (ADOPT) study. Supportive Care in Cancer journal
• Kubota, K., Kobayashi, W., Sakaki, H. et al. Support Care Cancer (2015) 23: 3323
• Mundipharma (2016) Development and Validation of an Attitudinal-Profiling Tool for Patients With Asthma
• L. Chanroux, L. Royel – A real world review of treatment duration and persistence among European psoriasis patients. AAD 2016.
• Klonoff D, Nayberg I, Erbstein F, Cali A, Brulle-Wohlhueter C, Haak T. Usability of the Gla-300 injection device compared with three other commercialized disposable insulin pens: results of an interview-based survey. J Diabetes Sci Technol. 2015
• Mundipharma (2015) Current practices in cancer pain management in Asia: a survey of patients and physicians across 10 countries
• L. Chanroux. Remission in Psoriasis: a Review of Real World Patient Cases. EADV 2015
• L. Chanroux. Early treatment in Rheumatoid Arthritis and its Effect on Patient Outcomes. ACR 2014
• D. Kottler. Investigating factors affecting time to initiation of hepatitis treatment. Viral Hepatitis Congress 2014.
• L. Chanroux. Reviewing “real-world” patient cases to better understand disease remission in CD and the management of relapses. UEGW 2014
• M. Yates, P. Teh. Stimulated consultations – presenting a window into the world of patient-physician interactions. EphMRA Tokyo Local Chapter Meeting 2014
• R. Head, S. West. I Marks the Spot – how an innovative mobile methodology dug up hidden insights into patient compliance. BHBIA Annual Conference 2014
• L. Chanroux. Use of Biologic Monotherapy among Rheumatoid Arthritis Patients: Investigating Clinical Drivers for Treatment Choice. EULAR 2014
• S. Marett, N. Barclay. Patient preferences for oral versus injectable and intravenous methods for Rheumatoid Arthritis. ISPOR 2013
• L. Chanroux, K. Johnson, J. Casellas. The Evolving Use Of Biologic Monotherapy In Rheumatoid Arthritis and Its Impact On Patient Outcomes. ACR 2013
• Tschiedel B, Almeida O, Redfearn J, Flacke F, Initial Experience and Evaluation of Reusable Insulin Pen Devices among Patients with Diabetes in Emerging Countries, Diabetes Technology Meeting 2013
• Jeffery M, Johnson K, Stokes A. Patient Preferences for TNF Antagonise Administration Methods. ACR 2013
• Janssen EMEA. (2013). Diabetes in the Downturn: Impact of the economic downturn on the management of diabetes in Europe